Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Handling Breakages in the Filling Line – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Handling Breakages in the Filling Line – V 2.0

Standard Operating Procedure for Handling Breakages in the Filling Line


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/035/2025
Supersedes SOP/SIM/035/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To establish a standardized procedure for managing glass vial or ampoule breakages during the filling and sealing of sterile injectable products to prevent contamination, ensure personnel safety, and maintain product

quality.

2. Scope

This SOP is applicable to all sterile filling operations involving vials, ampoules, or prefilled syringes conducted in the aseptic filling area of the Sterile Injectable Manufacturing department.

3. Responsibilities

  • Machine Operator: Immediately stops the machine and reports any breakage.
  • Production Supervisor: Oversees the cleaning, decontamination, and documentation of breakage.
  • QA Executive: Assesses impact, ensures proper cleaning, and authorizes re-start of filling.
  • Maintenance Personnel: Assists in equipment clearance and resetting post-breakage.
See also  Sterile Injectable Manufacturing: SOP for Formulation Development of Intraosseous Injections - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that all breakages during filling are managed as per SOP and that necessary preventive actions are implemented.

5. Procedure

5.1 Identification of Breakage

  1. Operators must visually monitor for vial/ampoule breakages at each stage: feeding, filling, sealing, and unloading.
  2. Upon breakage detection, immediately press the emergency stop button.
  3. Inform Production Supervisor and QA without delay.

5.2 Isolation and Containment

  1. Do not attempt to remove broken containers with bare hands. Use sterile forceps or scoop.
  2. Place broken glass and spilled product into a designated yellow-colored biohazard container.
  3. If any product contamination is suspected, the line must be declared contaminated until cleared by QA.

5.3 Cleaning and Disinfection

  1. Wear full PPE including gloves, face mask, and eye protection.
  2. Remove any unbroken containers in the immediate area.
  3. Use sterile lint-free wipes soaked in 70% IPA to wipe the affected surface.
  4. Use a vacuum cleaner with HEPA filter for removing microglass particles if applicable.
  5. Dispose of all cleaning materials as per hazardous waste SOP.

5.4 Quality Assurance Evaluation

  1. QA shall evaluate the scope of the incident to determine batch disposition risk.
  2. Review prior and subsequent units around the breakage point for integrity and labeling issues.
  3. QA shall complete and sign off the Breakage Incident Report (Annexure-1).
See also  Sterile Injectable Manufacturing: SOP for Particulate Matter Testing in Sterile Injections - V 2.0

5.5 Line Clearance and Re-initiation

  1. After complete cleaning, QA shall perform a visual check and record findings in the Line Clearance Log (Annexure-2).
  2. Only after QA approval shall the machine be restarted.
  3. Document the breakage, its location, quantity, and actions taken in the BMR and Annexure-3.

5.6 Preventive Measures

  1. Check alignment of conveyors and guides regularly to avoid container jams.
  2. Ensure correct handling of vials/ampoules during feeding.
  3. Train operators in safe breakage handling protocols quarterly (Annexure-4).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • BMR: Batch Manufacturing Record
  • IPA: Isopropyl Alcohol

7. Documents

  1. Breakage Incident Report – Annexure-1
  2. Line Clearance Log – Annexure-2
  3. Breakage Documentation Log – Annexure-3
  4. Operator Training Record – Annexure-4

8. References

  • WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • ICH Q9 – Quality Risk Management
See also  Sterile Injectable Manufacturing: SOP for Use of Cleaning Agents in Sterile Equipment Cleaning - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Breakage Incident Report

Date Batch No. Breakage Location No. of Units Handled By Remarks
18/06/2025 INJ-3562 Sealing Station 2 Sunil Patil Minor spill, cleaned

Annexure-2: Line Clearance Log

Date Batch No. Area Cleared By (QA) Comments
18/06/2025 INJ-3562 Filling Line A Ritika Joshi Cleared post-breakage

Annexure-3: Breakage Documentation Log

Date Batch No. Stage Breakage Count QA Notified Action Taken
18/06/2025 INJ-3562 Unloading 1 Yes Cleaned and documented

Annexure-4: Operator Training Record

Name Department Training Date Trainer Remarks
Vikas Pawar Production 01/06/2025 QA Executive Trained on SOP 035

Revision History

Revision Date Revision No. Details Reason Approved By
20/02/2022 1.0 Initial release New SOP QA Head
18/06/2025 2.0 Added training and HEPA cleaning protocol Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: BA-BE Studies: SOP for Handling Analytical Equipment Breakdowns – V 2.0
Next Post: Gel Manufacturing: SOP for Visual Inspection of Gel Batches – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version